Literature DB >> 18680541

Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.

A Ruffatti1, S Olivieri, M Tonello, M Bortolati, E Bison, E Salvan, M Facchinetti, V Pengo.   

Abstract

BACKGROUND: While medium to high titers of anticardiolipin (aCL) antibodies, defined as >40 GPL units or >99th percentile, is a laboratory criteria for the 'definite' diagnosis of antiphospholipid syndrome (APS), agreement between the two cut-offs has not been validated.
OBJECTIVE: To validate the current aCL laboratory criterion by verifying the effect of the two cut-offs on APS classification. PATIENTS/
METHODS: Ninety aCL positive APS patients were selected on the basis of their GPL values above the 99th percentile (17.4 GPL), which was calculated by testing 100 age- and sex-matched healthy subjects.
RESULTS: A significant difference in the IgG positivity (P < 0.0001) was found between the APS laboratory profiles as 20 out of the 24 (83.3%) patients with single positivity (aCL alone), six out of the 23 (26.1%) with double positivity (aCL plus lupus anticoagulant or anti-beta(2)glycoprotein I), and none out of the 43 with triple positivity (aCL plus lupus anticoagulant and anti-beta(2)glycoprotein I) had titers between the 99th percentile and 40 GPL units. Moreover, the rate of aCL values between the 99th percentile and 40 GPL units was significantly higher (P < 0.0001) in patients with pregnancy morbidity (73.7%) as compared to those with vascular thrombosis (16.9%) and those with both conditions (16.7%).
CONCLUSION: The 99th percentile cut-off level seems more sensitive than the >40 GPL value for APS classification, as it includes subjects with aCL positivity alone as well as patients with pregnancy morbidity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680541     DOI: 10.1111/j.1538-7836.2008.03121.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  10 in total

1.  APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.

Authors:  Brenda B Suh-Lailam; Anndorie Cromar; K Wayne Davis; Anne E Tebo
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.

Authors:  Marta Tonello; Antonia Calligaro; Maria Favaro; Teresa Del Ross; Paola Veronese; Elisa Salvan; Maria Teresa Gervasi; Amelia Ruffatti
Journal:  Arch Gynecol Obstet       Date:  2020-09-03       Impact factor: 2.344

3.  What's new in obstetric antiphospholipid syndrome.

Authors:  D Ware Branch
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

4.  Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification.

Authors:  Laura Vanoverschelde; Hilde Kelchtermans; Jacek Musial; Bas de Laat; Katrien M J Devreese
Journal:  Res Pract Thromb Haemost       Date:  2019-05-26

5.  Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome.

Authors:  Katrien M J Devreese; Stéphane Zuily; Pier Luigi Meroni
Journal:  J Transl Autoimmun       Date:  2021-11-06

6.  Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review.

Authors:  Gilberto Pires da Rosa; Ester Ferreira; Bernardo Sousa-Pinto; Ignasi Rodríguez-Pintó; Iva Brito; Alberto Mota; Ricard Cervera; Gerard Espinosa
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

7.  Diagnosis of antiphospholipid syndrome in routine clinical practice.

Authors:  C Gardiner; J Hills; S J Machin; H Cohen
Journal:  Lupus       Date:  2012-09-17       Impact factor: 2.911

8.  Association of anticardiolipin, antiphosphatidylserine, anti-β2 glycoprotein I, and antiphosphatidylcholine autoantibodies with canine immune thrombocytopenia.

Authors:  Yu-Chen Chen; Lang-Ming Chi; Kuan-Chih Chow; Shiow-Her Chiou; Yi-Hsin Fan; Shu-Peng Ho; Yu-Chen Hsu; Yu-Chyi Hwang; Meng-Xing Wu; Wei-Ming Lee; Shiun-Long Lin; Chau-Loong Tsang; Frank Chiahung Mao
Journal:  BMC Vet Res       Date:  2016-06-13       Impact factor: 2.741

9.  The Clinical Performance of a New Chemiluminescent Immunoassay in Measuring Anti-β2 Glycoprotein 1 and Anti-Cardiolipin Antibodies.

Authors:  Jiansuo Zhou; Xiuzhu Hou; Hua Zhang; Tiancheng Wang; Liyan Cui
Journal:  Med Sci Monit       Date:  2018-09-26

10.  Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.

Authors:  Shulan Zhang; Ziyan Wu; Ping Li; Yina Bai; Fengchun Zhang; Yongzhe Li
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.